PetMed Express Inc. (PETS)
NASDAQ: PETSConsumer StaplesRetail-Drug Stores and Proprietary StoresUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
PETS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $18.90M
- EPS (TTM)
- -$1.29
- Dividend yield
- None
- Ex-dividend date
- Aug 11, 2023
- 52-week range
- 0.8466 – 4.10
- Day range
- 0.8466 – 0.9115
- Volume / Avg
- 115.65K / 118.20K
- Beta
- —
- Shares outstanding
- 22.23M
52-week range
PETS stock today
PetMed Express (PETS) closed at $0.8501 on Nov 20, down 8.04% (-$0.0743), versus the S&P 500's 3.70% decline. At this level, PETS sits near the bottom of its 52-week range of $0.8466 to $4.10: 79.3% below the high, set on Dec 16, 2025 and 0.4% above the low. PETS is down 73.4% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 47.2%.
PetMed Express has posted a net loss over the last twelve months (EPS of -$1.29), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About PetMed Express
Company profilePetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
- Sector
- Consumer Staples
- Industry
- Retail-Drug Stores and Proprietary Stores
- CEO
- Ms. Leslie C. G. Campbell
- Headquarters
- Delray Beach, FL
- Employees
- 189
- Website
- 1800petmeds.com
Financial highlights
Full financialsIn fiscal 2026, PetMed Express generated $179.0 million in revenue, down 21.1% from fiscal 2025, its first annual decline since 2025. PetMed Express reported a net loss of $57.3 million, compared with a loss of $6.3 million a year earlier. Gross margin was 28.1% (down from 30.5%) and operating margin -32.8%.
| Fiscal year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Revenue | $179.02M | $226.97M | $274.10M | $247.57M | $272.28M |
| Growth | -21.13% | -17.19% | +10.71% | -9.08% | -10.31% |
| Net income | $-57.29M | $-6.27M | $-7.46M | $5.14M | $18.72M |
| EPS (diluted) | $-2.74 | $-0.30 | $-0.37 | $0.25 | $0.92 |
Analyst forecast
ForecastConsensus (1 analysts)
sell
Avg. price target
$1.40+64.69%
- Strong buy 0
- Buy 0
- Hold 0
- Sell 1
- Strong sell 0
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 10, 2026
- EPS actual vs est.
- $-0.31 vs $-0.11
- Surprise
- -181.82%
Dividends
Dividend history- Annual dividend
- $0.00
- Last payment
- $0.30
- Ex-dividend date
- Aug 11, 2023
PETS news
All PETS news- PetMeds® Announces Second Quarter Financial ResultsGlobeNewswire
- PetMed Express Q2 27 Earnings Conference Call At 4:30 PM ETNasdaq
- PetMeds Expands Retail Pharmacy Reach Through Pet Supermarket PartnershipNasdaqPETS, LEN.B
- PetMed Express, Inc. to Report Second Quarter Fiscal Year 2027 Financial Results on Tuesday, November 10, 2026GlobeNewswire
PetMed Express peers
Consumer Staples sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| YI111 Inc. ADR | 2.36 | -5.98% | $20.76M | vs PETS |
| RDGTRidgetech Inc. | 0.94 | -7.44% | $3.41M | vs PETS |
| GRDNGuardian Pharmacy Services Inc. Class A | 46.94 | +0.58% | $2.97B | vs PETS |
| CVSCVS Health Corporation | 80.84 | +1.00% | $103.43B | vs PETS |
Indexes, lists and sector
PetMed Express stock FAQ
What is PetMed Express's stock price today?
PETS last traded at $0.8501 as of Nov 20, 4:00 PM EST, down 8.04% on the day. Prices are delayed at least 15 minutes.
Does PetMed Express pay a dividend?
Yes. PetMed Express pays $0.00 per share annually. The most recent dividend of $0.30 had an ex-dividend date of Aug 11, 2023.
Who is PetMed Express's CEO?
Ms. Leslie C. G. Campbell is the chief executive officer of PetMed Express Inc., which has about 189 employees.
What is the PETS 52-week high?
The 52-week high for PETS is $4.10 and the 52-week low is $0.8466. The stock is currently 79.3% below its high.